SBRT for prostate cancer: Challenges and features from a physicist prospective

Area of Science:

• Medical Physics
• Radiation Oncology
• Oncology

Background:

• Stereotactic Body Radiation Therapy (SBRT) is increasingly recognized for its safety and efficacy in prostate cancer treatment.
• Medical physicists play a crucial role in evaluating and advancing SBRT technology for prostate cancer.
• Key physics challenges include mitigating geometrical uncertainties and achieving highly conformal dose distributions to spare organs at risk (OARs).

Purpose of the Study:

• To analyze the technological and physics aspects of SBRT for prostate cancer.
• To explore the rationale behind reducing treatment fractions and increasing dose per fraction (hypofractionation).
• To examine considerations for extreme hypofractionation schemes (>6-7 Gy per fraction) and associated safe treatment technologies.

Main Methods:

• A non-systematic review of SBRT technology and physics principles in prostate cancer management.
• Analysis focused on the technical requirements for hypofractionation and dose conformity.
• Evaluation of technological solutions for safe SBRT delivery in prostate cancer.

Main Results:

• Reducing the number of fractions in SBRT requires careful consideration of dose per fraction and geometrical accuracy.
• Achieving highly conformal dose distributions is essential for maximizing sparing of OARs.
• Technological advancements are crucial for the safe and effective delivery of prostate SBRT, particularly with hypofractionation.

Conclusions:

• Physics-driven advancements are critical for optimizing Stereotactic Body Radiation Therapy in prostate cancer.
• Minimizing geometrical uncertainties and enhancing dose conformity are paramount for safe and effective SBRT.
• Further development of SBRT technology is needed to support hypofractionation strategies and improve patient outcomes.